Skip to main content
. 2022 Nov 30;8(12):e11948. doi: 10.1016/j.heliyon.2022.e11948

Table 2.

Multilevel linear models for excess death rate.

Dimension of the predictor variables Predictor variables
Time-adjusted regression coefficient
95% CI
p-value
Time- and confounder-adjusted regression coefficient
95% CI
p-value
Time (phase) 12.392 (0.422, 24.362) 0.042 -9.040 (-16.971, -1.108) 0.025
Box A. Social, political and economic determinants GDP per capita (thousand USD) 4.736 (-1.644, 11.116) 0.146 - - -
Poverty (%) -0.913 (-2.139, 0.313) 0.144 - - -
Gini coefficient for income -148.271 (-451.733, 155.192) 0.338 - - -
Average per capita monthly income (USD) 0.215 (-0.021, 0.452) 0.074 - - -
Urban population (%) 0.876 (0.249, 1.502) 0.006 - - -
Box B. Factors outside the health sector Unemployment rate (%) 8.443 (5.506, 11.380) <0.001 - - -
Overcrowded conditions (%) -3.104 (-6.385, 0.177) 0.064 - - -
Access to improved water sources (%) 0.665 (0.082, 1.249) 0.025 - - -
Access to improved sanitation facilities (%) 0.939 (0.205, 1.673) 0.012 - - -
Years of schooling (median) 9.216 (2.140, 16.292) 0.011 - - -
Box C. Factors within the health sector Health insurance (%) -1.284 (-2.137, -0.431) 0.003 - - -
Density of human resources for health (per 10,000 population) -1.518 (-3.426, 0.389) 0.119 - - -
Per capita health expenditure (USD) -1.342 (-2.246, -0.439) 0.004 - - -
Healthcare access (per 100,000 population) -0.006 (-0.008, -0.004) <0.001 -0.004 (-0.005, -0.002) <0.001
Box D. Pandemic COVID-19 interventions Per capita expenditure of COVID-19 pandemic health budget (USD) -1.204 (-1.905, -0.502) 0.001 - - -
Number of COVID-19 test (per 100,000 population) 0.059 (0.005, 0.007) <0.001 - - -
Box E. Exposure and susceptibility factors People with comorbidities (%) 2.052 (0.179, 3.925) 0.032 - - -
People currently smoking (%) 0.927 (-2.895, 4.749) 0.635 - - -
Box F. Covid-19 infections COVID-19 Incidence (per 100,000 population) 0.062 (0.051, 0.072) <0.001 0.052 (0.042, 0.063) <0.001

Values represent time-adjusted coefficients and 95% coefficient interval (CI). Comorbidities included hypertension, diabetes mellitus and obesity.